AACR: Combination treatment is well-tolerated, shows antitumor effects in KRAS G12C-mutated metastatic colorectal cancer
ABSTRACT CT013Credit: The University of Texas MD Anderson Cancer Center ABSTRACT CT013 SAN DIEGO ― Combining the KRAS G12C inhibitor ...